Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newtown, Pennsylvania
- Most recent report
- 8-K, filed Oct 23, 2026
- Incorporated
- Delaware
- Filings on record
- 989 filings
- On EDGAR
- CIK 1130598
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 60
News 8 of 227
- 8-K Significant contract Oct 23, 2026
- 8-K Quarterly results Aug 14, 2026
- 8-K Current report on a material event Jul 31, 2026
- 8-K Other events Jul 10, 2026
- 8-K Leadership change Jul 9, 2026
- 8-K Current report on a material event Jun 22, 2026
- 8-K Current report on a material event Jun 12, 2026
- 8-K Current report on a material event May 27, 2026
Prospectuses and Registrations 8 of 92
- S-1 Registration statement for an offering Oct 26, 2026
- 424B5 Prospectus supplement for an offering Jul 10, 2026
- S-3 Shelf registration statement Jul 1, 2026
- 424B5 Prospectus supplement for an offering May 22, 2026
- 424B3 Prospectus supplement for an offering May 15, 2026
- S-3 Shelf registration statement May 8, 2026
- 424B5 Prospectus supplement for an offering Apr 7, 2025
- 424B5 Prospectus supplement for an offering Mar 10, 2025
Proxies 8 of 52
- DEFA14A Extra proxy material Oct 20, 2026
- DEF 14A Proxy statement for a shareholder vote Oct 20, 2026
- PRE 14A Preliminary proxy statement Oct 8, 2026
- DEFA14A Extra proxy material May 29, 2026
- DEF 14A Proxy statement for a shareholder vote May 29, 2026
- PRE 14A Preliminary proxy statement May 19, 2026
- DEFA14A Extra proxy material Oct 8, 2025
- DEF 14A Proxy statement for a shareholder vote Oct 8, 2025
Ownership 8 of 450
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- 4 Insider reported a trade Jul 16, 2026
- 4 Insider reported a trade Jul 15, 2026
- 4 Insider reported a trade Jul 15, 2026
- 4 Insider reported a trade Jul 14, 2026
Other 8 of 108
- D Nov 5, 2026
- EFFECT Notice that a registration became effective Jul 9, 2026
- CORRESP Reply to SEC staff Jul 7, 2026
- UPLOAD Comment letter from SEC staff Jul 7, 2026
- ARS Annual report sent to shareholders May 29, 2026
- EFFECT Notice that a registration became effective May 15, 2026
- CORRESP Reply to SEC staff May 13, 2026
- UPLOAD Comment letter from SEC staff May 12, 2026
Everything here comes from Traws Pharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.